ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Breast Cancer

Prostate Cancer trials near St Louis, MO, USA:

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Saint Louis, Missouri, United States and 8 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Saint Louis, Missouri, United States and 15 other locations

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate...

Enrolling
Biochemical Recurrence of Malignant Neoplasm of Prostate
Prostate Adenocarcinoma
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Saint Louis, Missouri, United States and 21 other locations

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Saint Louis, Missouri, United States and 107 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Saint Louis, Missouri, United States and 16 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Drug: Saruparib (AZD5305)
Drug: Darolutamide

Phase 1

AstraZeneca
AstraZeneca

Saint Louis, Missouri, United States and 16 other locations

This trial is a prospective clinical trial designed to demonstrate the safety and feasibility of whole-pelvis adaptive prostate stereotactic...

Enrolling
Prostate Cancer
Cancer of the Prostate
Device: Ethos Varian treatment system
Drug: Androgen deprivation therapy
The Washington University
The Washington University

Saint Louis, Missouri, United States

to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Saint Louis, Missouri, United States and 1 other location

This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...

Enrolling
Prostate Cancer
Drug: ARX517

Phase 1

Ambrx

Saint Louis, Missouri, United States and 8 other locations

period of time (for a maximum of 2 years (32 cycles) or until radiographic progression) on the treatment of castrate-resistant, metastatic prostate...

Active, not recruiting
Metastatic Cancer
Castration-resistant Prostate Cancer
Biological: pTVG-AR
Biological: pTVG-HP

Phase 2

University of Wisconsin (UW)
University of Wisconsin (UW)

Saint Louis, Missouri, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems